Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Investigation of a Quality Check for Plasma Samples

ABSTRACT: Plasma samples from healthy volunteers were used for the microarray analysis. The fresh sample and intentionally hemolyzed one due to negative pressure were examined. Microarray analyses were performed using the 3D-Gene microRNA microarray platform, and RNA extraction was conducted according to the manufacturer’s instructions. Only a very small amount of total RNA was present in the plasma samples; therefore 2 out of the 4 µl of total RNA extracted from 300- µl of plasma samples were used in microarray experiments.

ORGANISM(S): Homo sapiens

PROVIDER: GSE76954 | GEO | 2016/01/20

SECONDARY ACCESSION(S): PRJNA309129

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Investigation of a Quality Check for Plasma Samples

Project description:Plasma samples from healthy volunteers were used for the microarray analysis. The fresh sample and intentionally hemolyzed one due to negative pressure were examined. Microarray analyses were performed using the 3D-Gene microRNA microarray platform, and RNA extraction was conducted according to the manufacturerâs instructions. Only a very small amount of total RNA was present in the plasma samples; therefore 2 out of the 4 Âµl of total RNA extracted from 300- Âµl of plasma samples were used in microarray experiments. The purpose of this study is to identify hemolysis related microRNA. Plasma samples from healthy volunteers were used for the microarray analysis. The fresh sample and intentionally hemolyzed one due to negative pressure were examined.

2016-01-20 | E-GEOD-76954 | biostudies-arrayexpress

Screening for altered plasma miRNAs in traumatic brain injured patients

2011-04-06 | GSE21854 | GEO

Screening for altered plasma miRNAs in traumatic brain injured patients

Project description:In this study, we examined if the composition of plasma miRNAs is altered in patients with traumatic brain injury (TBI), and if these changes can be used as diagnostic markers. A microarray containing 875 human miRNAs was used to compare the miRNA profile of plasma collected from severe TBI patients (GCS M-bM-^IM-$ 8) to that of age-, gender-, and race-matched healthy volunteers. This screen identified 108 miRNAs in the plasma of healthy volunteers. Of these, 52 were found to be altered in plasma samples from persons with severe TBI, and an additional 8 miRNAs were detected only in the plasma of TBI patients. Plasma samples from 10 patients from either severe TBI (experimental group) or healthy volunteers (reference group; age-, gender-, and race-matched ) were pooled, the total RNA extracted in parallel, eluted in 100ul, and dried to 30 ul. Equal volumes of extracted plasma RNAs were assayed for global miRNA content using a service provider (LC Sciences, Houston, TX). There were no replicates performed for this screen. Healthy volunteer group served as the reference.

2011-04-06 | E-GEOD-21854 | biostudies-arrayexpress

Plasma exosome microRNA sequencing of Legg-Cavé-Perthes disease

Project description:We performed the miRNA-seq analysis of 3 plasma exosomes from Legg-Cavé-Perthes patients and 3 plasma exosomes from healthy volunteers based on the Illumina Hiseq 2500 platform and obtained data of 6 samples.

2022-04-05 | GSE171044 | GEO

Profiling of circulating microRNAs in patients with Barrett’s esophagus and esophageal adenocarcinoma

Project description:miRNAs were extracted from plasma samples of healthy volunteers, patients with Barrett’s esophagus and patients with esophageal adenocarcinoma. We used the Serum / Plasma Focus miRNA PCR panel (Exiqon, Denmark) to quantitate miRNA presence in the different patient groups.

2015-11-19 | GSE51410 | GEO

Detection of plant microRNAs in EVOO and plasma samples of healthy volunteers 2 hours postingestion of 40 mL of EVOO.

Project description:NGS has been applied to microRNA-enriched RNA obtained from Extra Virgin Olive Oil (EVOO), beer and plasma samples of healthy volunteers that usually consume EVOO hours after the ingestion of 40 mL of EVOO. Results: We did not detect significant amount of microRNA in the EVOO samples. Plasma samples did not contain EVOO microRNAs nor other microRNAs from plant origin.

2016-06-30 | GSE76735 | GEO

Detection of plant microRNAs in EVOO and plasma samples of healthy volunteers 2 hours postingestion of 40 mL of EVOO.

2016-06-30 | E-GEOD-76735 | biostudies-arrayexpress

Differential expression profiles of plasma tsRNAs in children with fulminant myocarditis

Project description:We report the application of high-throughput RNA sequencing technology to examine expression profiling of plasma transfer RNA (tRNA)-derived small RNAs (tsRNAs) in children with fulminant myocarditis during acute phase (FM-A group), children with fulminant myocarditis during convalescent phase (FM-C group), and healthy volunteers (Con group). A total of 750 precisely matched tsRNAs were identified in the plasma from the three groups. We find that a total of 13 tsRNAs were differentially expressed in FM-A and CON samples, of which 11 tsRNAs were upregulated and 2 were downregulated, and 694 tsRNAs were excluded ; a total of 8 tsRNAs were differentially expressed in paired FM-C and CON samples, of which 2 tsRNAs were upregulated and 6 were downregulated and 703 tsRNAs were excluded . This study provides new ideas for future research on elucidating the mechanisms of myocarditis through regulating tsRNAs levels.

2020-12-29 | GSE163944 | GEO

Phenotypic and genotypic relationships between meat quality characteristics and expression of target genes associated with broiler meat quality defects

Project description:The objective of this project was to employ customized Agilent 8x60 chicken whole genome microarray to identify differentially expressed genes associated with white striping (WS) and wooden breast (WB) defects in breast meat collected from commercial broilers with different slaughter age. Following harvest of chicken breasts (n = 184), the breast samples were classified as based on their appearance into non-defect, WS or WB. The defective samples were further grouped based on defect severity (WS = mild, moderate, severe; WB = moderate, severe). A total numbers of 40 samples were selected to represent various degree of the defects. Total RNA from deep-frozen skeletal muscle was isolated, integrity check (RIN > 7.0) and subjected for one-colored microarray hybridization according to Agilent’s instruction. The array was designed (design ID: AMADID G4102A084792) based on the National Center for Biotechnology Information (NCBI) Gallus gallus Annotation Release 103 (https://www.ncbi.nlm.nih.gov/genome/annotation_euk/Gallus_gallus/103/). Differential gene expression (p-value < 0.05) was confirmed using qPCR and droplet digital PCR. Biological pathways associated with WS and WB were identified.

2018-05-01 | GSE107362 | GEO